Jean‐Louis David

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Medicine, Pharmacology, Pharmacotherapy +10

Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist

Fred De Clerck, Jean‐Louis David, Paul A. J. Janssen · Inflammation Research · 1982 · 166 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study.

Raymond Limet, Jean‐Louis David, P Magotteaux et al. · PubMed · 1987 · 146 citations

Medicine, Pharmacotherapy, Surgery +16

Prevention of aorta-coronary bypass graft occlusion

Raymond Limet, Jean‐Louis David, P Magotteaux et al. · Journal of Thoracic and Cardiovascular Surgery · 1987 · 121 citations

Medicine, Cardiology, Surgery +12

Effect of Ticlopidine on Saphenous Vein Bypass Patency Rates: A Double-blind Study

M. Chevigné, Jean‐Louis David, P. Rigo et al. · The Annals of Thoracic Surgery · 1984 · 70 citations

Medicine, Pharmacology, Surgery +8